Operating income before deduction of amortization: China Pharma Holdings, Inc. (CPHI)

Brandmark of China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings (CPHI) is developing a digital pharmacy environment by attracting IT talent. Operating profit in cash terms reflects the asset's current dynamics, where the value of 0.00 shows the latest figure. Revenue growth is driven by generics and the demand for antibiotics across PRC regions. Business efficiency is increasing through the implementation of automated tablet molding and packaging lines.

China Pharma Holdings (CPHI) Operating profit EBITDA: for the period 11/23/2025 - 11/17/2026

Summary analytical data breakdowns for China Pharma Holdings, Inc. (CPHI)

- share price and consensus valuation forecast:
- company stock exchange capitalization indicators:
Summary company analytics:CPHI - chinapharmaholdings.com
Brand item of chinapharmaholdings.com

China Pharma Holdings' expansion into the branded generics and pharmacy distribution segments is directly reflected in the actual operating profit, which currently stands at 0.00. This metric measures the cash flow from core operations before depreciation and taxes, allowing investors to assess the real efficiency of the business model and the company's scaling pace relative to its historical peaks.